Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia
- PMID: 21852960
- PMCID: PMC3154963
- DOI: 10.1371/journal.pgen.1002229
Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia
Abstract
Although significant variations in the metabolic profiles exist among different cells, little is understood in terms of genetic regulations of such cell type-specific metabolic phenotypes and nutrient requirements. While many cancer cells depend on exogenous glutamine for survival to justify the therapeutic targeting of glutamine metabolism, the mechanisms of glutamine dependence and likely response and resistance of such glutamine-targeting strategies among cancers are largely unknown. In this study, we have found a systematic variation in the glutamine dependence among breast tumor subtypes associated with mammary differentiation: basal- but not luminal-type breast cells are more glutamine-dependent and may be susceptible to glutamine-targeting therapeutics. Glutamine independence of luminal-type cells is associated mechanistically with lineage-specific expression of glutamine synthetase (GS). Luminal cells can also rescue basal cells in co-culture without glutamine, indicating a potential for glutamine symbiosis within breast ducts. The luminal-specific expression of GS is directly induced by GATA3 and represses glutaminase expression. Such distinct glutamine dependency and metabolic symbiosis is coupled with the acquisition of the GS and glutamine independence during the mammary differentiation program. Understanding the genetic circuitry governing distinct metabolic patterns is relevant to many symbiotic relationships among different cells and organisms. In addition, the ability of GS to predict patterns of glutamine metabolism and dependency among tumors is also crucial in the rational design and application of glutamine and other metabolic pathway targeted therapies.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer.Cell Rep. 2019 Oct 1;29(1):76-88.e7. doi: 10.1016/j.celrep.2019.08.076. Cell Rep. 2019. PMID: 31577957 Free PMC article.
-
Dysregulation of glutaminase and glutamine synthetase in cancer.Cancer Lett. 2019 Dec 28;467:29-39. doi: 10.1016/j.canlet.2019.09.011. Epub 2019 Sep 28. Cancer Lett. 2019. PMID: 31574293 Review.
-
1,25-Dihydroxyvitamin D Regulation of Glutamine Synthetase and Glutamine Metabolism in Human Mammary Epithelial Cells.Endocrinology. 2017 Dec 1;158(12):4174-4188. doi: 10.1210/en.2017-00238. Endocrinology. 2017. PMID: 29029014 Free PMC article.
-
Glutamine and cancer.J Nutr. 2001 Sep;131(9 Suppl):2539S-42S; discussion 2550S-1S. doi: 10.1093/jn/131.9.2539S. J Nutr. 2001. PMID: 11533309 Review.
-
Mechanisms governing the expression of the enzymes of glutamine metabolism--glutaminase and glutamine synthetase.J Nutr. 2001 Sep;131(9 Suppl):2467S-74S; discussion 2486S-7S. doi: 10.1093/jn/131.9.2467S. J Nutr. 2001. PMID: 11533295
Cited by
-
Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production.Curr Issues Mol Biol. 2024 May 13;46(5):4646-4687. doi: 10.3390/cimb46050282. Curr Issues Mol Biol. 2024. PMID: 38785550 Free PMC article. Review.
-
GLUL stabilizes N-Cadherin by antagonizing β-Catenin to inhibit the progresses of gastric cancer.Acta Pharm Sin B. 2024 Feb;14(2):698-711. doi: 10.1016/j.apsb.2023.11.008. Epub 2023 Nov 9. Acta Pharm Sin B. 2024. PMID: 38322340 Free PMC article.
-
Genetic estimation of correlations between circulating glutamine and cancer.Am J Cancer Res. 2023 Dec 15;13(12):6072-6089. eCollection 2023. Am J Cancer Res. 2023. PMID: 38187059 Free PMC article.
-
Ammonia scavenger and glutamine synthetase inhibitors cocktail in targeting mTOR/β-catenin and MMP-14 for nitrogen homeostasis and liver cancer.Med Oncol. 2023 Dec 29;41(1):38. doi: 10.1007/s12032-023-02250-z. Med Oncol. 2023. PMID: 38157146
-
Research progress of metabolomics in cervical cancer.Eur J Med Res. 2023 Dec 13;28(1):586. doi: 10.1186/s40001-023-01490-z. Eur J Med Res. 2023. PMID: 38093395 Free PMC article. Review.
References
-
- Chi JT, Rodriguez EH, Wang Z, Nuyten DS, Mukherjee S, et al. Gene expression programs of human smooth muscle cells: tissue-specific differentiation and prognostic significance in breast cancers. PLoS Genet. 2007;3:e164. doi: 10.1371/journal.pgen.0030164. - DOI - PMC - PubMed
-
- Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–752. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources